WASHINGTON — The U.S. Food and Drug Administration (FDA) announced a significant policy shift on Tuesday, May 20, 2025, stating it will no longer routinely approve annual COVID-19 booster shots for healthy younger adults and children without new clinical trials. The decision, unveiled under the Trump administration, marks a departure from previous vacci…
FDA Shifts COVID-19 Vaccine Policy, Halting Routine Boosters for Healthy Adults and Children
FDA Ends Routine COVID-19 Boosters for Healthy Groups, Sparking Debate Over Vaccine Strategy
